BNTX
Price
$98.08
Change
-$1.67 (-1.67%)
Updated
Sep 25 closing price
Capitalization
23.58B
38 days until earnings call
KYMR
Price
$54.56
Change
+$0.82 (+1.53%)
Updated
Sep 26, 11:02 AM (EDT)
Capitalization
3.84B
34 days until earnings call
Interact to see
Advertisement

BNTX vs KYMR

Header iconBNTX vs KYMR Comparison
Open Charts BNTX vs KYMRBanner chart's image
BioNTech SE American Depositary Share
Price$98.08
Change-$1.67 (-1.67%)
Volume$591.73K
Capitalization23.58B
Kymera Therapeutics
Price$54.56
Change+$0.82 (+1.53%)
Volume$1.52K
Capitalization3.84B
BNTX vs KYMR Comparison Chart in %
Loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNTX vs. KYMR commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Buy and KYMR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BNTX: $98.08 vs. KYMR: $53.74)
Brand notoriety: BNTX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 62% vs. KYMR: 154%
Market capitalization -- BNTX: $23.58B vs. KYMR: $3.84B
BNTX [@Biotechnology] is valued at $23.58B. KYMR’s [@Biotechnology] market capitalization is $3.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, BNTX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 6 bullish TA indicator(s).

  • BNTX’s TA Score: 5 bullish, 6 bearish.
  • KYMR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than BNTX.

Price Growth

BNTX (@Biotechnology) experienced а +1.84% price change this week, while KYMR (@Biotechnology) price change was +5.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

BNTX is expected to report earnings on Nov 03, 2025.

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($23.6B) has a higher market cap than KYMR($3.84B). KYMR YTD gains are higher at: 33.569 vs. BNTX (-13.927). BNTX has higher annual earnings (EBITDA): -72.1M vs. KYMR (-267.03M). BNTX has more cash in the bank: 14B vs. KYMR (665M). KYMR has less debt than BNTX: KYMR (85.7M) vs BNTX (270M). BNTX has higher revenues than KYMR: BNTX (2.88B) vs KYMR (44.7M).
BNTXKYMRBNTX / KYMR
Capitalization23.6B3.84B614%
EBITDA-72.1M-267.03M27%
Gain YTD-13.92733.569-41%
P/E Ratio161.76N/A-
Revenue2.88B44.7M6,438%
Total Cash14B665M2,105%
Total Debt270M85.7M315%
FUNDAMENTALS RATINGS
BNTX: Fundamental Ratings
BNTX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXKYMR
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
74%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 25 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PDO14.000.10
+0.72%
PIMCO Dynamic Income Opportunities Fund
XHYT35.34N/A
N/A
BondBloxx US HY Telecm Md Tech Sctr ETF
CZAR32.42N/A
N/A
Themes Natural Monopoly ETF
TPHD38.86-0.24
-0.62%
Timothy Plan High Dividend Stock ETF
TGOPF52.07-0.81
-1.52%
3i Group

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-1.67%
MRNA - BNTX
54%
Loosely correlated
-4.91%
SMMT - BNTX
49%
Loosely correlated
-1.17%
KYMR - BNTX
48%
Loosely correlated
+2.35%
ARCT - BNTX
43%
Loosely correlated
-0.68%
TIL - BNTX
43%
Loosely correlated
-5.24%
More